GGrantIndex
← Search

PILOT--BREAST CANCER

$0P30FY2001CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

The Breast Cancer Program at the University of Southern California (USC)/Norris Comprehensive Cancer Center (NCC) is a focused interdisciplinary research program devoted to breast cancer. The scientific aims of the program are 1) to Test hypotheses of breast cancer etiology and pathogenesis with a particular emphasis on diverse racial/ethnic groups within Los Angeles County, 2) To identify differences in breast cancer mortality among racial ethnic groups of Los Angeles County and formulate strategies to lower mortality among all groups. 3) To characterize molecular genetic alterations in breast cancers with a focus on potential clinical utility, 4) To formulate and assess various strategies for breast cancer prevention, and 5) To develop and/or evaluate novel therapies for breast cancer; to enroll patients on local or national therapeutic protocols related to breast cancer, particularly emphasizing minority patient recruitment. The USC/Norris Breast Cancer Program takes advantage of the extraordinary, racial-ethic diversity among the 10 million residents of Los Angeles County, the population served by the NCCC. A major goal of the Program is to better understand the reasons for the underlying differences in breast cancer incidence, mortality and survival among the numerically most important of these racial-ethnic groups in the County (African-Americans, Latinas, Japanese, Chinese, Filipinas, Koreans and non-Latina whites). We have a multifaceted approach involving epidemiology and prevention scientists, behavioral scientists, tumor biologists and molecular geneticists, and radiation surgical and medical oncologists. Numerous patient and data resources are used to achieve this goal. These include the Los Angeles County SEER cancer registry program; a registry of breast cancer in twins; dietary and lifestyle data from recently characterized large racial- ethnically diverse cohorts; a large and diverse clinical population seen at NCCC affiliated hospitals; and several large tumor and other biological sample banks for studies of tumor biology and molecular genetics. The integrated multi-disciplinary Lee Breast Center has been built in the Hospital providing an environment favorable to patient care and clinical research. Recruitment of study subjects to clinical investigations has been strengthened during the last funding period. The overall annual research budget for the Program is in excess of $7 million. Four members of the Breast Cancer Program have been named to endowed Chairs in the NCCC. Funding has been provided for recruitment of new faculty, an annual program retreat, pilot research projects, and startup research funds for recruited faculty.

View original record on NIH RePORTER →